Insulet

Q4 2025 in 10d Q3 2025 +2.84%Q2 2025 +9.54%Q1 2025 +20.65%Q4 2024 -1.90%Q3 2024 +11.99%Q2 2024 -4.31%Q1 2024 -5.51%Q4 2023 -4.30%Q3 2023 +18.05%Q2 2023 -11.95%Q1 2023 +2.42%Q4 2022 +2.29%Q3 2022 +19.60%Q2 2022 +2.38%Q1 2022 -16.78%Q4 2021 +8.88%Q3 2021 -1.28%Q2 2021 -1.31%Q1 2021 -11.44%Q4 2020 +2.28%Q3 2020 +14.60%Q2 2020 +1.12%Q1 2020 +5.36%Q4 2019 -13.17%Q3 2019 +9.85%Q2 2019 +18.40%Q1 2019 +13.96%Q4 2018 +5.15%Q3 2018 +0.36%Q2 2018 +2.41%Q1 2018 -3.55%Q4 2017 +3.65%Q3 2017 +18.88%Q2 2017 +6.53%Q1 2017 -5.77%Q4 2016 -5.22%Q3 2016 +9.85%Q2 2016 +18.53%Q1 2016 -4.03%Q4 2015 +8.95%Q3 2015 +13.17%Q2 2015 +9.96%Q1 2015 -10.99%Q4 2014 -4.54%Q3 2014 +5.06%Q2 2014 -2.16%Q1 2014 -14.03%Q4 2013 +3.54%Q3 2013 -3.39%Q2 2013 +10.25%Q1 2013 +12.04%Q4 2012 +9.35%Q3 2012 +4.21%Q2 2012 +4.80%Q1 2012 +2.08%Q4 2011 -3.52%Q3 2011 +0.53%Q2 2011 +2.89%Q1 2011 +0.63%Q4 2010 -1.99%Q3 2010 +2.52%Q2 2010 +0.33%Q1 2010 +11.13%

Nov 05, 2019

•

Sep 30, 2019

Insulet Q3 2019 Earnings Report

Previous year: -$21.8M

Insulet

Unlock previous datapoints

Upgrade

Insulet

Unlock previous datapoints

Upgrade

Revenue by Segment

U.S. Omnipod Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

International Omnipod Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Drug Delivery Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Insulet

Products

Get in Touch

Resources

Insulet

Insulet Q3 2019 Earnings Report

Insulet

Insulet

Revenue by Segment

U.S. Omnipod Revenue

International Omnipod Revenue

Drug Delivery Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Company Overview

Insulet Revenue by Segment